Cargando…

Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China

Objective: The objective of this study is to determine the drug resistance status of pulmonary tuberculosis patients in Jilin Province. Methods: A retrospective survey was conducted on 395 sputum culture TB-positive patients admitted to the tuberculosis hospital in Jilin Province in 2019. Sputum sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Sichen, Li, Rui, Wang, Yue, Yang, Xin, Liu, Youbin, Cui, Ze, Tang, Hongfei, Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560708/
https://www.ncbi.nlm.nih.gov/pubmed/37818197
http://dx.doi.org/10.3389/fphar.2023.1263726
_version_ 1785117779965247488
author Sichen, Li
Rui, Wang
Yue, Yang
Xin, Liu
Youbin, Cui
Ze, Tang
Hongfei, Cai
author_facet Sichen, Li
Rui, Wang
Yue, Yang
Xin, Liu
Youbin, Cui
Ze, Tang
Hongfei, Cai
author_sort Sichen, Li
collection PubMed
description Objective: The objective of this study is to determine the drug resistance status of pulmonary tuberculosis patients in Jilin Province. Methods: A retrospective survey was conducted on 395 sputum culture TB-positive patients admitted to the tuberculosis hospital in Jilin Province in 2019. Sputum samples were cultured in acidic Roche medium. Drug sensitivity testing was conducted using the proportional method. Sensitivity was reported if the percentage of drug resistance was less than 1%, and resistance was reported if the percentage was ≥1%. Statistical analysis was performed using SPSS 22.0. Results: 395 tuberculosis patients with positive sputum tuberculosis culture were included in the study, with 102 being initially treated and 293 being retreated. The study population consisted of 283 males and 112 females. Sex, age, nationality, occupation, marital status, diabetes comorbidity, initial treatment, normal health status, BCG vaccine vaccination, smoking, and alcohol consumption were considered as factors that may affect the rate of multidrug resistance. And only the history of treatment (initial treatment) was associated with multidrug resistance (p = 0.032). This indicates that retreatment is the most significant risk factor for the occurrence of multidrug resistance in tuberculosis. The multidrug resistance rate in retreated patients is 3.764 times higher than that in initially treated patients. Conclusion: The prevalence of multidrug-resistant is higher in retreated patients compared to initially treated patients in the study population. Multidrug resistance is only associated with the treatment history (initial retreatment) and not with other factors.
format Online
Article
Text
id pubmed-10560708
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105607082023-10-10 Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China Sichen, Li Rui, Wang Yue, Yang Xin, Liu Youbin, Cui Ze, Tang Hongfei, Cai Front Pharmacol Pharmacology Objective: The objective of this study is to determine the drug resistance status of pulmonary tuberculosis patients in Jilin Province. Methods: A retrospective survey was conducted on 395 sputum culture TB-positive patients admitted to the tuberculosis hospital in Jilin Province in 2019. Sputum samples were cultured in acidic Roche medium. Drug sensitivity testing was conducted using the proportional method. Sensitivity was reported if the percentage of drug resistance was less than 1%, and resistance was reported if the percentage was ≥1%. Statistical analysis was performed using SPSS 22.0. Results: 395 tuberculosis patients with positive sputum tuberculosis culture were included in the study, with 102 being initially treated and 293 being retreated. The study population consisted of 283 males and 112 females. Sex, age, nationality, occupation, marital status, diabetes comorbidity, initial treatment, normal health status, BCG vaccine vaccination, smoking, and alcohol consumption were considered as factors that may affect the rate of multidrug resistance. And only the history of treatment (initial treatment) was associated with multidrug resistance (p = 0.032). This indicates that retreatment is the most significant risk factor for the occurrence of multidrug resistance in tuberculosis. The multidrug resistance rate in retreated patients is 3.764 times higher than that in initially treated patients. Conclusion: The prevalence of multidrug-resistant is higher in retreated patients compared to initially treated patients in the study population. Multidrug resistance is only associated with the treatment history (initial retreatment) and not with other factors. Frontiers Media S.A. 2023-09-25 /pmc/articles/PMC10560708/ /pubmed/37818197 http://dx.doi.org/10.3389/fphar.2023.1263726 Text en Copyright © 2023 Sichen, Rui, Yue, Xin, Youbin, Ze and Hongfei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Sichen, Li
Rui, Wang
Yue, Yang
Xin, Liu
Youbin, Cui
Ze, Tang
Hongfei, Cai
Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
title Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
title_full Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
title_fullStr Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
title_full_unstemmed Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
title_short Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China
title_sort analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in northeast china
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560708/
https://www.ncbi.nlm.nih.gov/pubmed/37818197
http://dx.doi.org/10.3389/fphar.2023.1263726
work_keys_str_mv AT sichenli analysisofdrugresistanceinpulmonarytuberculosispatientswithpositivesputumtuberculosiscultureinnortheastchina
AT ruiwang analysisofdrugresistanceinpulmonarytuberculosispatientswithpositivesputumtuberculosiscultureinnortheastchina
AT yueyang analysisofdrugresistanceinpulmonarytuberculosispatientswithpositivesputumtuberculosiscultureinnortheastchina
AT xinliu analysisofdrugresistanceinpulmonarytuberculosispatientswithpositivesputumtuberculosiscultureinnortheastchina
AT youbincui analysisofdrugresistanceinpulmonarytuberculosispatientswithpositivesputumtuberculosiscultureinnortheastchina
AT zetang analysisofdrugresistanceinpulmonarytuberculosispatientswithpositivesputumtuberculosiscultureinnortheastchina
AT hongfeicai analysisofdrugresistanceinpulmonarytuberculosispatientswithpositivesputumtuberculosiscultureinnortheastchina